ATE405277T1 - Substitutions-infusionflüssigkeit und zitratanticoagulation - Google Patents

Substitutions-infusionflüssigkeit und zitratanticoagulation

Info

Publication number
ATE405277T1
ATE405277T1 AT00927004T AT00927004T ATE405277T1 AT E405277 T1 ATE405277 T1 AT E405277T1 AT 00927004 T AT00927004 T AT 00927004T AT 00927004 T AT00927004 T AT 00927004T AT E405277 T1 ATE405277 T1 AT E405277T1
Authority
AT
Austria
Prior art keywords
infusion fluid
substitution infusion
citrate anticoagulation
fluid
relates
Prior art date
Application number
AT00927004T
Other languages
English (en)
Inventor
Pe Chou Chang
Original Assignee
Edwards Lifesciences Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE405277(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edwards Lifesciences Ag filed Critical Edwards Lifesciences Ag
Application granted granted Critical
Publication of ATE405277T1 publication Critical patent/ATE405277T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672—Means preventing coagulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3424—Substitution fluid path
    • A61M1/3437—Substitution fluid path downstream of the filter, e.g. post-dilution with filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3455—Substitution fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3455—Substitution fluids
    • A61M1/3458—Substitution fluids having electrolytes not present in the dialysate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672—Means preventing coagulation
    • A61M1/3675—Deactivation

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00927004T 1999-04-26 2000-04-20 Substitutions-infusionflüssigkeit und zitratanticoagulation ATE405277T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99201302 1999-04-26

Publications (1)

Publication Number Publication Date
ATE405277T1 true ATE405277T1 (de) 2008-09-15

Family

ID=8240149

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00927004T ATE405277T1 (de) 1999-04-26 2000-04-20 Substitutions-infusionflüssigkeit und zitratanticoagulation

Country Status (7)

Country Link
US (1) US6743191B1 (de)
EP (1) EP1176969B1 (de)
AT (1) ATE405277T1 (de)
AU (1) AU4553700A (de)
DE (1) DE60039978D1 (de)
ES (1) ES2315228T3 (de)
WO (1) WO2000064456A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8105258B2 (en) * 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US7186420B2 (en) * 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
DE10114283C2 (de) * 2000-12-22 2003-04-24 Fresenius Medical Care De Gmbh Verfahren zur Ermittlung der Ionenkonzentration des Blutes eines Patienten bei der citrat-antikoagulierten Hämodialyse und/oder Hämofiltration; Dialysegerät
US7351218B2 (en) * 2002-12-20 2008-04-01 Gambro Lundia Ab Device and process for extracorporeal treatment by citrate anticoagulant
FR2848857B1 (fr) * 2002-12-20 2005-09-16 Gambro Lundia Ab Dispositif et ligne a usage unique pour le traitement extracorporel du sang par anticoagulation au citrate
ITMO20030293A1 (it) * 2003-10-29 2005-04-30 Gambro Lundia Ab Dispositivo per la determinazione del flusso di sangue in un circuito extracorporeo, nonche' apparecchiatura per il trattamento di sangue utilizzante lo stesso dispositivo.
SE0400523D0 (sv) * 2004-03-01 2004-03-01 Gambro Lundia Ab A medical solution, a method for producing said medical solution and use thereof
DE102004023828A1 (de) 2004-05-13 2005-12-08 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
WO2006020415A1 (en) * 2004-08-02 2006-02-23 Smithkline Beecham Corporation Chemical compounds
US7544301B2 (en) 2004-08-19 2009-06-09 Hhd Llc Citrate-based dialysate chemical formulations
SE0402507D0 (sv) 2004-10-14 2004-10-14 Gambro Lundia Ab Medicinsk lösning, förfarande för framställning och användning därav
US8372025B2 (en) * 2005-09-22 2013-02-12 Baxter International Inc. Automation and optimization of CRRT treatment using regional citrate anticoagulation
US7884132B2 (en) * 2005-11-14 2011-02-08 The Uab Research Foundation Process for metabolic control and high solute clearance and solutions for use therein
CA2643140C (en) * 2006-02-22 2014-12-09 Henry Ford Health System System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits
US8133194B2 (en) 2006-02-22 2012-03-13 Henry Ford Health System System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits
EP1897535A1 (de) * 2006-08-30 2008-03-12 Dirinco AG Substitutionsflüssigkeit für die Haemofiltration
US8133163B2 (en) 2006-10-03 2012-03-13 Smurfit-Stone Container Enterprises, Inc. Apparatus for forming a barrel from a blank
FR2920314B1 (fr) * 2007-09-05 2010-07-30 Gambro Lundia Ab Circuit de traitement extracorporel de sang et ligne ayant un site d'infusion pour le melange optimise de fluides
US9022913B2 (en) 2009-11-02 2015-05-05 Rock-Tenn Shared Services, Llc Methods and a machine for forming a container from a blank
US10463779B2 (en) * 2013-04-30 2019-11-05 Gambro Lundia Ab Multipart fluid system and a system for regional citrate anticoagulation with a phosphate comprising anticoagulation fluid
US10420797B2 (en) * 2013-04-30 2019-09-24 Gambro Lundia Ab Anticoagulation fluid comprising citrate and phosphate
DE102014013885A1 (de) * 2014-09-18 2016-03-24 Fresenius Medical Care Deutschland Gmbh Dialyselösung
DE102015015597A1 (de) * 2015-12-04 2017-06-08 Fresenius Medical Care Deutschland Gmbh Behandlung von Schlaganfall durch Hämofiltration
WO2020132389A1 (en) * 2018-12-20 2020-06-25 University Of Maryland, Baltimore Hemofiltration device, system and method for a high blood flow extracorporeal circuit
CN113597311A (zh) * 2018-12-28 2021-11-02 费森尤斯医疗护理德国有限责任公司 稳定的含水血液滤过置换基础液、透析溶液和相应的套件

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336881A (en) 1979-06-14 1982-06-29 Diachem, Inc. Aqueous acid concentrate for hemodialysis dialysate
JPS56128711A (en) 1980-03-12 1981-10-08 Hikari Seiyaku Kk Glucose-electrolyte preparation for high-calorie transfusion
US4308255A (en) 1980-03-24 1981-12-29 Haemophor Corporation Balanced oncotic pressure fluid
CA1166966A (en) 1980-05-09 1984-05-08 Albert L. Babb System for bicarbonate dialysate
US4489535A (en) 1980-10-02 1984-12-25 Veltman Preston Leonard Materials and method for preparing dialysis solutions containing bicarbonate ions
US4339433A (en) 1981-01-09 1982-07-13 Baxter Travenol Laboratories, Inc. Additives for peritoneal dialysis solutions
US4574085A (en) 1981-05-15 1986-03-04 Baxter Travenol Laboratories, Inc. Method for using dialysis solution containing glycerol
US4879280A (en) 1981-09-24 1989-11-07 Fresenius Ag Dialysis solution for use in intraperitoneal dialysis
EP0076355A3 (de) 1981-10-01 1983-05-25 Abbott Laboratories Lösung für die Peritoneal-Dialyse
DE3224823A1 (de) 1982-07-02 1984-01-05 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer fuer den entsprechenden krankheitsfall optimierten elektrolytloesung zur anwendung in der haemodialyse
US4886789A (en) 1983-01-12 1989-12-12 M. L. Laboratories Plc Peritoneal dialysis and compositions for use therein
GB8404299D0 (en) 1984-02-18 1984-03-21 Milner Research Ireland Ltd Peritoneal dialysis
US6077836A (en) 1983-01-12 2000-06-20 Ml Laboratotries, Plc Peritoneal dialysis and compositions for use therein
GB8300718D0 (en) 1983-01-12 1983-02-16 Milner Research Ireland Ltd Glucose polymer solutions
US4604379A (en) 1984-06-18 1986-08-05 Curators Of The University Of Missouri Dialysis solutions containing cross-linked gelatin
US4663166A (en) 1984-06-22 1987-05-05 Veech Richard L Electrolyte solutions and in vivo use thereof
US6020007A (en) 1984-06-22 2000-02-01 Btg International Limited Fluid therapy with l-lactate and/or pyruvate anions
JPS61247466A (ja) 1985-04-25 1986-11-04 テルモ株式会社 腹膜透析用透析液
US4690772A (en) 1985-06-03 1987-09-01 National Medical Care Sterilant compositions
US5192459A (en) 1985-06-03 1993-03-09 Erika, Inc. Sterilant compositions
US6248726B1 (en) 1985-06-22 2001-06-19 M L Laboratories Plc Method of peritoneal dialysis using glucose polymer solutions
JP2720165B2 (ja) 1988-03-24 1998-02-25 日本製薬株式会社 ぶどう糖電解質配合剤
DE3812524A1 (de) 1988-04-15 1989-10-26 Fresenius Ag Dialysier- und spuelloesung fuer die intraperitoneale verabreichung mit antimikrobieller ausruestung
DE3812525C1 (de) 1988-04-15 1989-06-22 Fresenius Ag, 6380 Bad Homburg, De
US4889634A (en) 1988-10-04 1989-12-26 Gynex, Inc. Dialysate solution containing hydroxypropyl-beta-cyclodextrin and method of using same
JPH02145522A (ja) 1988-11-28 1990-06-05 Tomita Seiyaku Kk ペースト状人工腎臓潅流用剤及びその製造方法
AU627309B2 (en) 1989-05-26 1992-08-20 Terumo Kabushiki Kaisha Preparation for blood dialysis and method for production thereof
DE3917251A1 (de) 1989-05-26 1990-11-29 Fresenius Ag Natriumbicarbonat enthaltendes konzentrat sowie verfahren zur herstellung einer dialysierfluessigkeit
US5252213A (en) 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
US4925665A (en) 1989-06-22 1990-05-15 Thomas Jefferson University Glucose free primary anticoagulant for blood containing citrate ions
US5032615A (en) * 1989-10-31 1991-07-16 The Regents Of The University Of California Continuous hemodialysis using citrate
DK0437274T3 (da) 1990-01-12 1994-10-10 Bartz Volker Bicarbonat- og calciumholdig infusions- og dialyseopløsning
JPH0469341A (ja) * 1990-07-05 1992-03-04 Otsuka Pharmaceut Factory Inc Ｔｐｎ用糖電解質液
DE4122754A1 (de) 1991-07-10 1993-01-21 Martin Prof Dr Med Vlaho Herstellung einer substitutionsloesung fuer die haemofiltration bei dialyseverfahren
DE4125819A1 (de) 1991-08-03 1993-02-04 Rolf Prof Dr Med Zander Waessrige loesung und deren verwendung
EP0555087B1 (de) 1992-02-04 1998-08-05 Baxter International Inc. Peritonealdialyselösungen die mindestens ein Dipeptid enthalten
DE59206619D1 (de) 1992-04-06 1996-07-25 Baxter Int Wässrige Peritonealdialyse-Lösung
US5827820A (en) 1992-04-06 1998-10-27 Baxter International Inc. Aqueous peritoneal dialysis solution
US5616248A (en) 1992-04-06 1997-04-01 Schal; Wilfried Method for the preparation of hemodialysis fluids containing bicarbonate
AU4239593A (en) 1992-06-03 1993-12-30 Minntech Corporation Method of hemodialysis and hemodialysis liquids including hydrochloric acid
ATE226433T1 (de) 1992-12-22 2002-11-15 Baxter Int Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse
US5589197A (en) 1993-10-04 1996-12-31 Baxter International, Inc. Low sodium peritoneal dialysis solution
US5436232A (en) 1994-01-07 1995-07-25 Laevosan-Gesellschaft Mbh Pharmaceutical composition for peritoneal dialysis
US6306836B1 (en) 1994-01-21 2001-10-23 Baxter International Inc. Peritoneal dialysis solutions containing maltodextrins and amino acids
BR9506021A (pt) 1994-07-01 1997-10-14 Baxter Int Solução de diálise peritoneal e processo para corrigir a acidose metabólica
WO1996018292A1 (en) * 1994-12-16 1996-06-20 Baxter International Inc. Controlling donor blood characteristics
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
SE9600631D0 (sv) 1996-02-20 1996-02-20 Gambro Ab Use of a solution comprising glucose for peritonial dialysis having reduced formation of AGE products
DE19631124A1 (de) 1996-08-01 1998-02-05 Fresenius Medical Care De Gmbh Verfahren zur Herstellung einer Bicarbonat enthaltenden Infusions- oder Dialysierlösung
AU3976697A (en) 1996-09-11 1998-04-02 Aksys, Ltd. Batch quantity dialysate chemical formulations
US6017942A (en) * 1996-10-31 2000-01-25 Baxter International Inc. Method and compositions for the treatment of renal failure
US5945449A (en) 1996-11-01 1999-08-31 Dialysis Solutions Inc. Sterile bicarbonate concentrate
DE19654746C2 (de) 1996-12-30 2000-05-11 Klaus Sodemann Dialyselösung
US6620120B2 (en) 1997-05-22 2003-09-16 Nephros, Inc. Method for high efficiency hemofiltration
GB9714218D0 (en) 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
EP1008341B1 (de) 1997-08-22 2004-06-30 Shimizu Pharmaceutical Co., Ltd. Glukose enthaltende zubereitung
SE510587C2 (sv) 1997-10-07 1999-06-07 Gambro Lundia Ab Koncentrat för dialyslösning och användning därav
SE9703775L (sv) 1997-10-16 1999-04-17 Pharmalink Baslaekemedel Ab Framställning av sterial lösningar som innehåller glukos
US5955257A (en) * 1997-10-21 1999-09-21 Regents Of The University Of Minnesota Infusible grade short-term cell storage medium for mononuclear cells
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
JPH11279051A (ja) * 1998-03-30 1999-10-12 Nikkiso Co Ltd 透析用剤及びその製造方法
EP0958832B1 (de) 1998-05-21 2006-01-25 Nipro Corporation Albumin enthaltende Lösung für die Peritonealdialyse
JP2000072658A (ja) 1998-06-17 2000-03-07 Nissho Corp 腹膜透析液および腹膜透析法
US6156797A (en) 1998-07-07 2000-12-05 Terumo Kabushiki Kaisha Peritoneal dialysis solution
JP2000037452A (ja) 1998-07-21 2000-02-08 Terumo Corp 腹膜透析液
JP3871442B2 (ja) 1998-08-11 2007-01-24 テルモ株式会社 腹膜透析液
DE19850830B4 (de) 1998-11-04 2004-12-30 Fresenius Medical Care Deutschland Gmbh Verfahren zur Herstellung einer Lösung, insbesondere einer Dialyse- oder Infusionslösung
SE9804248D0 (sv) 1998-12-07 1998-12-07 Global Hemostasis Inst Mgr Ab Anti-coagulation with calcium containing citrate solution
JP4284737B2 (ja) 1999-02-26 2009-06-24 株式会社ジェイ・エム・エス 中性腹膜透析液
DE19912850B4 (de) 1999-03-22 2005-04-07 Fresenius Medical Care Deutschland Gmbh Lösung, insbesondere für Hämo- oder Peritonealdialyse, sowie Verfahren zu deren Herstellung
JP3951284B2 (ja) 1999-06-07 2007-08-01 ニプロ株式会社 透析用固形製剤およびその製造方法
US6251437B1 (en) 1999-07-13 2001-06-26 Minntech Corporation Liquid/powder acid concentrate for dialysate and a method of making the same
US6309673B1 (en) 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy

Also Published As

Publication number Publication date
US6743191B1 (en) 2004-06-01
ES2315228T3 (es) 2009-04-01
EP1176969A2 (de) 2002-02-06
WO2000064456A3 (en) 2001-08-09
WO2000064456A2 (en) 2000-11-02
EP1176969B1 (de) 2008-08-20
DE60039978D1 (de) 2008-10-02
AU4553700A (en) 2000-11-10

Similar Documents

Publication Publication Date Title
ATE405277T1 (de) Substitutions-infusionflüssigkeit und zitratanticoagulation
SE9702860D0 (sv) New use
WO2003035142A3 (en) Catheter for modified perfusion
BR0317450A (pt) Fluidos de diálise biocompatìveis contendo icodextrinas
DE60325404D1 (de) Gerät zur bestimmung der dialyse-effizienz
PL371200A1 (en) A haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
ATE371467T1 (de) Dentales behandlungsgerat
SE9600631D0 (sv) Use of a solution comprising glucose for peritonial dialysis having reduced formation of AGE products
DE60025698D1 (de) Neue dialysemethode
DE60115432D1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
ATE28570T1 (de) Schlauchsystem fuer behandlung von blut und aenhlichen leichtverderblichen fluessigkeiten ausserhalb des koerpers.
BR9713653B1 (pt) composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço farmacÊutica, e, uso de pirofosfato fÉrrico.
AU2001261987A1 (en) Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
KR960702315A (ko) 혈관 차단 치료에서의 헤모글로빈의 치료적 용도 (Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage)
DE69227042D1 (de) Verfahren und zusammensetzungen zur verminderung von blutverlust
NZ514911A (en) Use of N-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients
SE0301546L (sv) Biokompatibel polymer
CN208524974U (zh) 一种普外科用镊子
Retief, DJ, Dreyer, CJ, Retief, DH & Lemmer Induced exchange of fluids in the treatment of post-traumatic infective lesions-a preliminary report
CN205586038U (zh) 一种用于外周血管的压迫止血器
Downing et al. Intravenous cannula fixing and dressing--comparison between the use of transparent polyurethane dressing and conventional technique
Quinton et al. Historical Milestones in Daily Dialysis Cannulation of blood vessels for prolonged hemodialysis.
UA39355A (uk) Спосіб визначення "сухої ваги" і оптимального обсягу ультрафільтрації у хворих, що лікуються програмним гемодіалізом
UA31309A (uk) Спосіб лікування захворювань системи кровообігу
UA29143A (uk) Спосіб лікування гнійної інфекції

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties